Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: metastatic
New Prostate Cancer Drug Approved by FDA
Good news for patients with metastatic prostate cancer. The FDA (US Food and Drug Administration) has approved Johnson & Johnson’s Zytiga (abiraterone) in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy. Abiraterone … Continue reading →
Posted in Cancer, Prostate cancer
|
Tagged abiraterone, cabazitaxel, FDA, Jevtana, Johnson & Johnson, metastatic, Prostate cancer, Provenge, sipuleucel-T, Zytiga
|
1 Comment
Europe Approved Sutent for Rare Pancreatic Cancer
The European Commission has recently approved Sutent (sunitinib) as a medicine for treating patients with pancreatic neuroendocrine tumors (NET). The drug is now indicated to treat unresectable metastatic, well-differentiated pancreatic NET in adults with disease progression. The approval was based … Continue reading →
Posted in Cancer, Pancreatic Cancer
|
Tagged metastatic, Pancreatic Cancer, pancreatic neuroendocrine tumors, progression-free survival, sunitinib, Sutent
|
Comments Off on Europe Approved Sutent for Rare Pancreatic Cancer
Good News for Women Who Have HER2-Positive, Herceptin-resistant, Metastatic Breast Cancer
A study published in the March issue of the Journal of Clinical Oncology indicated that breast cancer patients who have HER2/neu gene, but have failed Herceptin therapy, can now receive Tykerb, in addition to their Hercpetin, to improve their length of time … Continue reading →
Posted in Breast cancer, Cancer
|
Tagged Breast cancer, Cardiovascular disease, Her2, Herceptin, metastatic, Tykerb
|
Comments Off on Good News for Women Who Have HER2-Positive, Herceptin-resistant, Metastatic Breast Cancer
